May or may not influ: BRAF mutation is common in Papillary Thyroid cancer. Some data suggests that it may make the prognosis worse but it is not well established and therefore does not affect initial choice of treatment like Radioactive Iodine use and its effectiveness.
Answered 9/6/2016
1k views
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
7 doctors weighed in across 3 answers
2 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question